Zomedica (ZOMDF) EBITDA Margin (2021 - 2026)
Zomedica's EBITDA Margin came in at -23.55% for Q2 2026, up 64.25 percentage points from -87.79% a year earlier and up 10.65 percentage points from the prior quarter.
Powered by 
Analysis
Zomedica (ZOMDF) EBITDA Margin (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Zomedica reported EBITDA Margin of -35.80%, up 246.22 percentage points year-over-year; for FY2025, it was -238.53%, down 80.69 percentage points from FY2024.
- EBITDA Margin has declined in each of the last three years, though with a four-year change of +229.90 percentage points (FY2021 to FY2025).
- Going back by year, EBITDA Margin was -157.84% in FY2024 (-11.03 pp), -146.82% in FY2023 (-52.36 pp), -94.46% in FY2022 (+373.98 pp) and -468.43% in FY2021.
- The Q2 2026 figure represents the highest quarterly EBITDA Margin in data going back to Q1 2021.
- Year-over-year, EBITDA Margin has increased for five consecutive quarters, with an average year-over-year change of +90.28 percentage points over the last eight quarters.
- The fastest year-over-year change in EBITDA Margin over five years came in Q2 2022 (a gain of 32580.36 percentage points), and the weakest in Q1 2025 (a drop of 823.96 percentage points).
- Business Quant data shows ZOMDF's EBITDA Margin at -34.20% (Q1 2026), -31.02% (Q4 2025) and -58.13% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 39.16% |
| 10 | Zomedica | 78.40 Mn | -119.63 Mn | 6.04 Mn | -23.55% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.55% |
| Mar 31, 2026 | -34.20% |
| Dec 31, 2025 | -31.02% |
| Sep 30, 2025 | -58.13% |
| Jun 30, 2025 | -87.79% |
| Mar 31, 2025 | -958.98% |
| Dec 31, 2024 | -77.39% |
| Sep 30, 2024 | -77.35% |
| Jun 30, 2024 | -376.61% |
| Mar 31, 2024 | -135.02% |
| Dec 31, 2023 | -288.97% |
| Sep 30, 2023 | -68.57% |
| Jun 30, 2023 | -87.59% |
| Mar 31, 2023 | -112.17% |
| Dec 31, 2022 | -63.41% |
| Sep 30, 2022 | -113.86% |
| Jun 30, 2022 | -100.89% |
| Mar 31, 2022 | -73.53% |
| Dec 31, 2021 | -120.98% |
| Sep 30, 2021 | -27,395.65% |
API Access
Zomedica EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ZOMDF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ZOMDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ZOMDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();